The CoaguChek INRange system helps patients and doctors monitor coagulation and response to Vitamin K Antagonist (VKA) therapy. Patients on VKA therapy usually have to visit the hospital or a doctor's office for PT/INR testing done with a needle, and then wait for lab results. Roche's system uses a fingerstick and 60-second test to generate results. The system could also help improve adherence and outcomes for patients. Data show that self-testing has been linked to individuals spending more time at normal INR levels and lower rates of stroke or bleeding.
CoaguChek INRange includes Bluetooth technology and facilitate communication between doctors and patients. Data suggest that individuals who have a strong link to their physician better adhere to anticoagulant treatment. This new Coaguchek INRangecould enable the clinicians to access the test results in the clinic's database, to keep track of the individual patient's status and to measure the quality of care provided by the clinic." In a clinical environment, a model of care that empowers patients, helping them to understand their health condition and allowing them to take responsibility of their own health care needs will definitively improve outcome. In Belgium each year 1000 patients died because of non well managed VKA treatment.